[1] Pennathur A, Gibson MK, Jobe BA, et al. Oesophageal carcinoma [J]. Lancet, 2016, 381(9864): 400-412.
[2] Duvic M, Vu J. Vorinostat: a new oral histone deacetylase inhibitor approved for cutaneous T-cell lymphoma [J]. Expert Opin Investig Drugs, 2007, 16(7): 1111-1120.
[3] Shi X, Zheng C, Li C, et al. 4-Phenybutyric acid promotes gastric cancer cell migration via histone deacetylase inhibition-mediated HER3/HER4 up-regulation [J]. Cell Biol Int, 2018, 42(1): 53-62.
[4] Kong D, Ahmad A, Bao B, et al. Histone deacetylase inhibitors induce epithelial-to-mesenchymal transition in prostate cancer cells [J]. PLoS One, 2012, 7(9): e45045.
[5] Fei YF, Qiu GK, Luo HB, et al. Histone deacetylase inhibitor TSA-induced epithelial-mesenchymal transition by upregulating Slug in colorectal cancer cells [J]. Anhui Medicine, 2017, 21(10): 1776-1780. (in Chinese)
费云飞,邱广阔,罗洪波,等.组蛋白去乙酰化酶抑制剂曲古抑菌素通过上调Slug促进结直肠癌细胞上皮间质转化的研究 [J]. 安徽医药, 2017, 21(10): 1776-1780.
[6] Wang J, Xu MQ, Jiang XL, et al. Histone deacetylase inhibitor SAHA-induced epithelial-mesenchymal transition by upregulating Slug in lung cancer cells [J]. Anticancer Drugs, 2018, 29(1): 80-88.
[7] Xu W, Liu H, Liu ZG, et al. Histone deacetylase inhibitors upregulate Snail via Smad2/3 phosphorylation and stabilization of Snail to promote metastasis of hepatoma cells [J]. Cancer Lett, 2018, 28(420):1-13.
[8] Gon?alves RM, Agnes JP, Delgobo M. Late autophagy inhibitor chloroquine improves efficacy of the histone deacetylase inhibitor SAHA and temozolomide in gliomas [J]. Biochem Pharmacol, 2019, 163: 440-450.
[9] Chavan AV, Somani RR. HDAC inhibitors-new generation of target specific treatment [J]. Mini Rev Med Chem, 2010, 10(13):1263-1276.
[10] Yao J, Qian CJ, Ye B, et al. ERK inhibition enhances TSA-induced gastric cancer cell apoptosis via NF-κB-dependent and Notch-independent mechanism[J]. Life Sci, 2012, 91(5-6): 186-193.
[11] Greenbryg G, Hay ED. Epithelia suspended in collagen gels can lose polarity and express characteristics of migrating mesenchymal cells [J]. J Cell Biol, 1982, 95(1): 333-339.
[12] Peinado H, Olmeda D, Cano A. Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype[J]? Nat Rev Cancer, 2007, 7(6): 415-428.
[13] Zhang X, Wang F, Huang Y, et al. FGG promotes migration and invasion in hepatocellular carcinoma cells through activating epithelial to mesenchymal transition [J]. Cancer Manag Res, 2019, 11:1653-1665.
[14] Zhan BT, Zhao H. The correlation between Slug expression and epithelial-mesenchymal transition and invasion in esophageal carcinoma [J]. Journal of Hainan Medical College, 2017, 23(10): 1391-1394. (in Chinese)
詹波涛,赵华.食管癌组织中Slug表达量与癌细胞上皮-间质转化及侵袭特性的相关性 [J].海南医学院学报, 2017, 23(10): 1391-1394.
[15] Wang XY, Liu HT, Hu YY. Study on the relationship between protein kinase C subclass and cAMP-PKA system in human lung cancer cells [J]. Journal of Anatomy, 1998, 29(4): 396-400. (in Chinese)
王向阳,柳惠图,胡云英.人肺癌细胞中蛋白激酶C亚类与cAMP-PKA系统相关性的研究[J]. 解剖学报, 1998, 29(4): 396-400.
[16] Liu SG, Wang BS, Jiang YY, et al. Typical protein kinase Cι (PKCι) promotes metastasis of esophageal squamous cell carcinoma by enhancing resistance to Anoikis via PKCι-SKP2-AKT pathway [J]. Mol Cancer Res, 2011, 9(4): 390-402.
[17] Lin KT, Wang YW, Chen CT, et al. HDAC inhibitors augmented cell migration and metastasis through induction of PKCs leading to identification of low toxicity modalities for combination cancer therapy [J]. Clin Cancer Res, 2012, 18(17): 4691-4701.
|